Scientists, researchers, practicing veterinarians, animal health companies and horse owners have long been dedicated to improving the health of the horse. Yet the need for more knowledge in regards to disease prevention, lameness and general wellness still exists.

At Boehringer Ingelheim Vetmedica, Inc., we're furthering our commitment to research efforts to ensure that we continue to learn more about equine diseases.

We are pleased to announce the third annual Boehringer Ingelheim Advancement in Equine Research Award Program. The deadline for submissions is October 15, 2013.

The 2013 Advancement in Equine Research Award recipients will be announced at the American Association of Equine Practitioners Conference in Nashville, Tennessee.

The BIVI Equine Research Award will focus on one specific equine disease area each year. For 2013, the equine disease of focus is equine infectious disease. 
Proposals must address one or more specific criteria to be considered:

  • Practical application and ability to improve the diagnosis, pathogenesis, transmission, control and/or prevention of equine infectious disease(s)
  • Disease(s) can be bacterial or viral etiologies

Boehringer Ingelheim will provide five $15,000 awards to the winning proposals for equine infectious disease research. Veterinarians, diagnosticians, public and private researchers in the United States and Canada are eligible to submit proposals for research programs that help advance the diagnosis, treatment and understanding of equine infectious disease(s). Winning proposals will be selected by an independent review board.

Once the five winning year-long research projects are completed and submitted for peer review, the Equine Research Review Board will conduct a second evaluation. Upon acceptance for publication of his or her findings, the first place award recipient will receive an additional U.S. $5,000; second place, $3,000; and third place, $1,000.

Our independent Equine Research Review Board members look forward to reviewing your proposals.

Find more information, including instructions for submissions, on the BIVI website.